Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1976 2
1977 2
1978 2
1979 1
1980 1
1981 1
1982 1
1983 3
1986 5
1987 1
1988 7
1989 1
1990 5
1991 4
1992 3
1993 3
1994 6
1995 3
1996 4
1997 1
1998 2
1999 1
2000 4
2001 3
2002 4
2003 2
2004 7
2005 5
2006 5
2007 2
2008 4
2009 3
2010 6
2011 8
2012 2
2013 4
2014 10
2015 4
2016 12
2017 10
2018 11
2019 4
2020 8
2021 6
2022 10
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "intermediate hepatic vein"
Page 1
Liver glucose metabolism in humans.
Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Adeva-Andany MM, et al. Biosci Rep. 2016 Nov 29;36(6):e00416. doi: 10.1042/BSR20160385. Print 2016 Dec. Biosci Rep. 2016. PMID: 27707936 Free PMC article. Review.
Information about normal hepatic glucose metabolism may help to understand pathogenic mechanisms underlying obesity and diabetes mellitus. ...The liver receives dietary carbohydrates directly from the intestine via the portal vein. Glucokinase phosphorylates glucose …
Information about normal hepatic glucose metabolism may help to understand pathogenic mechanisms underlying obesity and diabetes mell …
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma.
Chang Y, Jeong SW, Young Jang J, Jae Kim Y. Chang Y, et al. Int J Mol Sci. 2020 Oct 31;21(21):8165. doi: 10.3390/ijms21218165. Int J Mol Sci. 2020. PMID: 33142892 Free PMC article. Review.
Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of TACE for HCC. ...The anti-tumor effect of the two has been reported to be similar; however, DEB-T …
Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage hepatocellular carcinoma (HCC). In this review, …
Heterogeneity of HSCs in a Mouse Model of NASH.
Rosenthal SB, Liu X, Ganguly S, Dhar D, Pasillas MP, Ricciardelli E, Li RZ, Troutman TD, Kisseleva T, Glass CK, Brenner DA. Rosenthal SB, et al. Hepatology. 2021 Aug;74(2):667-685. doi: 10.1002/hep.31743. Epub 2021 Aug 10. Hepatology. 2021. PMID: 33550587 Free PMC article.
Our analysis of the normal liver identified two distinct clusters of quiescent HSCs that correspond to their acinar position of either pericentral vein or periportal vein. The NASH livers had four distinct HSC clusters, including one representing the classic fibroge …
Our analysis of the normal liver identified two distinct clusters of quiescent HSCs that correspond to their acinar position of either peric …
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
Pan Y, Mei J, Chen J, Zhang D, Wang J, Wang X, Yi M, Zhou Z, Zhang Y, Chen M, Guo R, Xu L. Pan Y, et al. Ann Surg Oncol. 2022 Mar;29(3):2016-2029. doi: 10.1245/s10434-021-10903-4. Epub 2021 Oct 12. Ann Surg Oncol. 2022. PMID: 34637058
BACKGROUND: Patients with intermediate to advanced stage hepatocellular carcinoma (HCC; Barcelona Clinic Liver Cancer [BCLC] stage B/C) have few choices of curable treatments and thus suffer from dismal outcomes. ...OBJECTIVE: This study was conducted to investigate the su …
BACKGROUND: Patients with intermediate to advanced stage hepatocellular carcinoma (HCC; Barcelona Clinic Liver Cancer [BCLC] stage B/ …
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P. Meyers RL, et al. Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22. Lancet Oncol. 2017. PMID: 27884679 Free PMC article. Clinical Trial.
To address this challenge, we formed a global coalition, the Children's Hepatic tumors International Collaboration (CHIC), with the aim of creating a common approach to staging and risk stratification in this rare cancer. ...Diagnostic factors found to be most prognostic o …
To address this challenge, we formed a global coalition, the Children's Hepatic tumors International Collaboration (CHIC), with the a …
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Llovet JM, Vogel A, Madoff DC, Finn RS, Ogasawara S, Ren Z, Mody K, Li JJ, Siegel AB, Dubrovsky L, Kudo M. Llovet JM, et al. Cardiovasc Intervent Radiol. 2022 Apr;45(4):405-412. doi: 10.1007/s00270-021-03031-9. Epub 2022 Feb 4. Cardiovasc Intervent Radiol. 2022. PMID: 35119481 Free PMC article. Clinical Trial.
PURPOSE: Transarterial chemoembolization (TACE) is the standard of care for patients with intermediate-stage hepatocellular carcinoma (HCC). Lenvatinib, a multikinase inhibitor, and pembrolizumab, a PD-1 inhibitor, have shown efficacy and tolerability in patients with HCC, …
PURPOSE: Transarterial chemoembolization (TACE) is the standard of care for patients with intermediate-stage hepatocellular carcinoma …
Role and Regulation of Wnt/beta-Catenin in Hepatic Perivenous Zonation and Physiological Homeostasis.
Goel C, Monga SP, Nejak-Bowen K. Goel C, et al. Am J Pathol. 2022 Jan;192(1):4-17. doi: 10.1016/j.ajpath.2021.09.007. Am J Pathol. 2022. PMID: 34924168 Free PMC article. Review.
These metabolic pathways are segregated along the portocentral axis of the liver lobule into three hepatic zones: periportal, intermediate or midzonal, and perivenous. ...However, dysregulation of Wnt/beta-catenin signaling is also implicated in different liver path …
These metabolic pathways are segregated along the portocentral axis of the liver lobule into three hepatic zones: periportal, inte …
Therapeutic options for intermediate-advanced hepatocellular carcinoma.
Zhang ZM, Guo JX, Zhang ZC, Jiang N, Zhang ZY, Pan LJ. Zhang ZM, et al. World J Gastroenterol. 2011 Apr 7;17(13):1685-9. doi: 10.3748/wjg.v17.i13.1685. World J Gastroenterol. 2011. PMID: 21483627 Free PMC article. Review.
Although surgical resection is a potentially curative modality for HCC, most patients with intermediate-advanced HCC are not suitable candidates. The current therapeutic modalities for intermediate-advanced HCC include: (1) surgical procedures, such as radical resec …
Although surgical resection is a potentially curative modality for HCC, most patients with intermediate-advanced HCC are not suitable …
Locoregional and systemic therapy for hepatocellular carcinoma.
Gbolahan OB, Schacht MA, Beckley EW, LaRoche TP, O'Neil BH, Pyko M. Gbolahan OB, et al. J Gastrointest Oncol. 2017 Apr;8(2):215-228. doi: 10.21037/jgo.2017.03.13. J Gastrointest Oncol. 2017. PMID: 28480062 Free PMC article. Review.
Management in this scenario depends on a number of factors including hepatic function, tumor burden, patency of hepatic vasculature and patients' functional status. ...Catheter directed intra-arterial therapy takes advantage of tumor hypervascularity and the unique …
Management in this scenario depends on a number of factors including hepatic function, tumor burden, patency of hepatic vascul …
A review of hepatic fibrosis-associated histopathology in aged cadavers.
Mak KM, Kee D, Cheng CP. Mak KM, et al. Anat Rec (Hoboken). 2023 May;306(5):1031-1053. doi: 10.1002/ar.24931. Epub 2022 Apr 21. Anat Rec (Hoboken). 2023. PMID: 35446463 Free article. Review.
This article reviews hepatic fibrosis-associated histopathology of aged cadavers (mean age 82 years). ...Concomitantly, intermediate hepatocyte-like cells increase in advanced fibrosis stages, which is possibly related to hepatic regeneration. ...
This article reviews hepatic fibrosis-associated histopathology of aged cadavers (mean age 82 years). ...Concomitantly, intermedia …
194 results